Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques

Neurology
L O RamigL Thompson

Abstract

The purpose of this study was to evaluate the long-term (12 months) effects of two forms of speech treatment on the speech and voice deficits that occur in Parkinson's disease. Thirty-five patients with idiopathic Parkinson's disease were assigned to one of two speech treatment groups: voice and respiration (The Lee Silverman Voice Treatment [LSVT]) or placebo (respiration) treatment. Vocal intensity data from before, immediately after, and at 6 and 12 months after speech treatment revealed statistically significant differences between the treatment groups. Only subjects in the LSVT group improved or maintained vocal intensity above pretreatment levels by 12 months after treatment. The placebo group had statistically significant deterioration of vocal intensity levels from before to 12 months after treatment during conversational monologue. The LSVT group did not deteriorate to levels below pretreatment in vocal intensity over the 12-month period. This study is the first to document the short-and long-term effects of intensive speech treatment (LSVT), which focuses on the voice, for patients with Parkinson's disease compared with a placebo speech treatment group.

Citations

Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine H O DeaneCarl E Clarke
Nov 21, 2007·Dysphagia·Roxann Diez GrossPatrick J Doyle
Mar 30, 2006·Current Treatment Options in Neurology·Daniel Tarsy
Sep 12, 2003·Journal of Communication Disorders·Jacqueline S Laures, Kate Bunton
Dec 29, 2000·Journal of Voice : Official Journal of the Voice Foundation·C A RosenM Sonbolian
Jan 2, 2007·Journal of Speech, Language, and Hearing Research : JSLHR·Jessica E Huber, Bharath Chandrasekaran
Jan 31, 2008·Journal of Speech, Language, and Hearing Research : JSLHR·Christy L LudlowChristine M Sapienza
May 29, 2008·Journal of Speech, Language, and Hearing Research : JSLHR·Jessica E Huber, John Spruill
Mar 10, 2011·Journal of Speech, Language, and Hearing Research : JSLHR·Meghan Darling, Jessica E Huber
Aug 22, 2012·Age and Ageing·Gordon W DuncanDavid J Burn
Sep 23, 2003·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Jennifer L SpielmanLorraine O Ramig
Jan 3, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J J FerreiraW H Oertel
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·L O RamigL L Thompson
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·A El SharkawiC Werner
Sep 29, 2011·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·Yunjung Kim, Christina Kuo
Aug 31, 2011·Parkinson's Disease·Tara L WhitehillMia M-N Chow
Feb 15, 2008·Expert Review of Neurotherapeutics·Lorraine O RamigShimon Sapir
Jul 11, 2012·Clinical Linguistics & Phonetics·Leslie A Mahler, Lorraine O Ramig
Sep 6, 2011·Journal of Communication Disorders·Jeff SearlRajesh Pahwa
Apr 13, 2010·Journal of Voice : Official Journal of the Voice Foundation·Sabine SkoddaUwe Schlegel
Sep 18, 2015·Neurologia i neurochirurgia polska·Wioletta PawlukowskaPrzemysław Nowacki
Sep 11, 2007·Archives of Physical Medicine and Rehabilitation·Talia HermanJeffrey M Hausdorff
Oct 10, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Amy N HillDon Donovan
Nov 1, 2015·Journal of Communication Disorders·Heidi MartensMarc De Bodt
Feb 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Neeraja Sadagopan, Jessica E Huber
Nov 21, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Marjolein A van der MarckMark Guttman
Dec 4, 2014·International Journal of Language & Communication Disorders·Sheila Wight, Nick Miller
Mar 18, 2010·Brain Research·John A RussellTimothy Schallert
Aug 25, 2004·Lancet Neurology·Serge PintoPascal Auzou
Oct 27, 2004·Neurologic Clinics·James Tetrud
Mar 22, 2015·Journal of Voice : Official Journal of the Voice Foundation·Marc De BodtAthenais Versele
Jun 25, 2015·Neurodegenerative Disease Management·Cyril Atkinson-ClementSerge Pinto
Oct 5, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Takashi TsuboiGen Sobue
May 7, 2015·Current Opinion in Otolaryngology & Head and Neck Surgery·Leslie A MahlerCynthia Fox
Sep 13, 2006·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·Kate Bunton
Jan 20, 2012·Developmental Neurorehabilitation·Leslie A Mahler, Harrison N Jones
Jan 22, 2015·Arquivos de neuro-psiquiatria·Luciana Lemos de AzevedoFrancisco Cardoso
Sep 14, 2000·Otolaryngologic Clinics of North America·J K Casper, T Murry
Aug 6, 2004·Clinical Rehabilitation·Heather Gage, Lesley Storey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.